Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Clinical trials demonstrate that patients on semaglutide lose weight consistently over 68 weeks, with many experiencing a 1522% reduction in body weight compared to 23% in the placebo group
Taniva does not make claims about individual outcomes, results or experiences
Patient Education Videos Forms and Resources
Tirzepatide: Adding a Second Metabolic Pathway Tirzepatide builds upon semaglutide by activating both: GLP-1 GIP (glucose-dependent insulinotropic polypeptide) Researchers believe activating both receptors may enhance metabolic regulation in some individuals
US$ 21.28
US$ 29.56
US$ 20.69
US$ 28.78
US$ 20.04
US$ 22.06
US$ 25.98
